Day One Biopharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Day One Biopharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Day One Biopharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 96.6M shares, a 12.4% increase year-over-year.
  • Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79.8M shares, a 21.9% increase from 2022.
  • Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 65.5M shares, a 77.1% increase from 2021.
  • Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 37M shares, a 568% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 96.6M +10.7M +12.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 87.1M +12.2M +16.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 86.7M +14.7M +20.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 79.8M +14.3M +21.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 86M +14.9M +21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 75M +14.2M +23.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 72M +13.6M +23.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 65.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 71M +13.5M +23.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 60.8M +38.1M +168% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 58.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-01
Q3 2021 57.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 22.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.